Pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended SEBI (‘PIT Regulations’) and in terms of Company's Code of Conduct, Everest Organics has informed that the trading window for dealing in the Company's securities by its Designated persons and their Immediate Relatives will remain closed from Wednesday, April 01, 2026 till 48 hours after the declaration of the Audited Financial Results for the quarter and financial year ending March 31, 2026. Further, the date of the Board Meeting for consideration and approval of Audited Financial Results of the Company for the quarter and financial year ending March 31, 2026 shall be intimated to the Stock Exchange in due course of time.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: